Axsome Therapeutics AXSM
NASDAQ AXSM
$186.14 -7.75 (-4.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Axsome Therapeutics (AXSM) EBT Margin (2022 - 2026)

Updated

Axsome Therapeutics (AXSM) recorded EBT Margin of -23.44% in Q2 2026, up 9.17 percentage points from -32.61% a year earlier and up 10.32 percentage points from the prior quarter.

Analysis

Axsome Therapeutics (AXSM) EBT Margin (2022 - 2026) Analysis & Trends

On a TTM basis, Axsome Therapeutics' EBT Margin came in at -24.61% as of Jun 30, 2026, up 25.45 percentage points year-over-year; for FY2025, it came in at -28.77%, up 45.67 percentage points from FY2024.

  • Annual EBT Margin has increased for three straight years, with a three-year change of +345.22 percentage points (FY2022 to FY2025).
  • Across earlier years, EBT Margin came in at -74.45% in FY2024 (+13.61 pp), -88.06% in FY2023 (+285.94 pp) and -373.99% in FY2022.
  • Quarterly EBT Margin has ranged from -469.82% in Q2 2022 to -9.13% in Q1 2023 over the past five years.
  • On a year-over-year basis, EBT Margin has increased for nine consecutive quarters, with an average year-over-year change of +41.27 percentage points over the last eight quarters.
  • Peak year-over-year performance for EBT Margin in the last five years was a gain of 324.66 percentage points in Q2 2023, against a drop of 82.01 percentage points in Q1 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at -33.76% (Q1 2026), -14.35% (Q4 2025) and -27.62% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 26.66%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 25.18%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -4.11%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 29.63%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 18.19%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 27.53%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -131.41%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -4.34%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 41.75%
10 Axsome Therapeutics 10.14 Bn 8.87 Bn 204.81 Mn -23.44%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -23.44%
Mar 31, 2026 -33.76%
Dec 31, 2025 -14.35%
Sep 30, 2025 -27.62%
Jun 30, 2025 -32.61%
Mar 31, 2025 -48.91%
Dec 31, 2024 -63.00%
Sep 30, 2024 -61.67%
Jun 30, 2024 -91.03%
Mar 31, 2024 -91.14%
Dec 31, 2023 -138.37%
Sep 30, 2023 -108.80%
Jun 30, 2023 -145.15%
Mar 31, 2023 -9.13%
Dec 31, 2022 -251.29%
Sep 30, 2022 -266.08%
Jun 30, 2022 -469.82%
API Access

Axsome Therapeutics EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=AXSM&period=max&api_key=YOUR_API_KEY